Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing

Oral Oncology

Volumn 46, Issue 7, 2010, Pages 492-496

  Robinson, Max ^a   Sloan, Philip ^a   Shaw, Richard ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Head and neck cancer; HPV; Molecular diagnosis; Oropharyngeal cancer; p16

Indexed keywords

PROTEIN P16; VIRUS DNA;

ALGORITHM; CANCER DIAGNOSIS; HEAD AND NECK CANCER; HIGH RISK BEHAVIOR; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; TONSIL CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77953359433     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.02.013     Document Type: Review

References (44)

1. Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384 (2009) 260-265
2. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 467-475
3. Fakhry C., and Gillison M.L. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24 (2006) 2606-2611
4. Shah K.V., and Westra W.H. Genital HPVs in the aerodigestive tract: etiologic association with a subset of oropharyngeal/tonsillar cancers and with recurrent respiratory papillomatosis. Dis Markers 23 (2007) 235-245
5. Hennessey P.T., Westra W.H., and Califano J.A. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res 88 (2009) 300-306
6. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Head and neck cancers. V.1.2009. .
7. Begum S., Gillison M.L., Ansari-Lari M.A., Shah K., and Westra W.H. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9 (2003) 6469-6475
8. Begum S., Gillison M.L., Nicol T.L., and Westra W.H. Detection of human papillomavirus 16 in fine needle aspirates to determine tumour origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 13 (2007) 1186-1191
9. Zhang M.Q., El-Mofty S.K., and Davila R.M. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridisation in fine needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary. Cancer 114 (2008) 118-123
10. Münger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78 (2004) 11451-11460
11. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
12. Hubbard R.A. Human papillomavirus testing methods. Arch Pathol Lab Med 127 (2003) 940-945
13. Brink A.A., Snijders P.J., and Meijer C.J. HPV detection methods. Dis Markers 23 (2007) 273-281
14. Smeets S.J., Hesselink A.T., Speel E.J., Haesevoets A., Snijders P.J., Pawlita M., et al. A novel algorithm for reliable detection of human papilomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121 (2007) 2465-2472
15. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Nat Cancer Inst 92 (2000) 709-720
16. Koskinen W.J., Chen R.W., Leivo I., Mäkitie A., Bäck L., Kontio R., et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107 (2003) 401-406
17. Wiest T., Schwarz E., Enders C., Flechtenmacher C., and Bosch F.X. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRB cell control. Oncogene 21 (2002) 1510-1517
18. Mellin H., Dahlgren L., Munck-Wikland E., Lindholm J., Rabbani H., Kalantari M., et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102 (2002) 152-158
19. Pett M., and Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?. J Pathol 212 (2007) 356-367
20. Fernandez A.F., Rosales C., Lopez-Nieva P., Graña O., Ballestar E., Ropero S., et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19 (2009) 438-451
21. Klussmann J.P., Gültekin E., Weissenborn S.J., Wieland U., Dries V., Dienes H.P., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162 (2003) 747-753
22. Begum S., Cao D., Gillison M., Zahurak M., and Westra W.H. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11 (2005) 5694-5699
23. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Brandsma J., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favourable prognosis. J Clin Oncol 24 (2006) 736-747
24. Reimers N., Kasper H.U., Weissenborn S.J., Stützer H., Preuss S.F., Hoffmann T.K., et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120 (2007) 1731-1738
25. Westra W.H. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol 3 (2009) 78-81
26. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case control study of human papillomavirus and oropharyngeal cancer. N Eng J Med 356 (2007) 1944-1956
27. Gillison M.L., D'Souza G., Westra W., Sugar E., Xiao W., Begum S., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100 (2008) 407-420
28. Fakhry C., Westra W.H., Li S., Cmelak A., Ridge J.A., Pinto H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008) 261-269
29. Braakhuis B.J., Brakenhoff R.H., Meijer C.J., Snijders P.J., and Leemans C.R. Human papillomavirus in head and neck cancer: the need for a standardised assay to assess the full clinical importance. Eur J Cancer 45 (2009) 2935-2939
30. Braakhuis B.J., Snijders P.J., Keune W.J., Meijer C.J., Ruijter-Schippers H.J., Leemans C.R., et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96 (2004) 998-1006
31. Snijders P.J., Steenbergen R.D., Top B., Scott S.D., Meijer C.J., and Walboomers J.M. Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 75 (1994) 2769-2775
32. Barten M., Ostwald C., Milde-Langosch K., Müller P., Wukasch Y., and Löning T. HPV DNA and p53 alterations in oropharyngeal carcinomas. Virchows Arch 427 (1995) 153-157
33. Scholes A.G., Liloglou T., Snijders P.J., Hart C.A., Jones A.S., Woolgar J.A., et al. P53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer 71 (1997) 796-799
34. Sisk E.A., Soltys S.G., Zhu S., Fisher S.G., Carey T.E., and Bradford C.R. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24 (2002) 841-849
35. Westra W.H., Taube J.M., Poeta M.L., Begum S., Sidransky D., and Koch W.M. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 14 (2008) 366-369
36. Ragin C.C., Taioli E., Weissfeld J.L., White J.S., Rossie K.M., Modugno F., et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95 (2006) 1432-1438
37. Smeets S.J., Braakhuis B.J., Abbas S., Snijders P.J., Ylstra B., van de Wiel M.A., et al. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene 25 (2006) 2558-2564
38. Klussmann J.P., Mooren J.J., Lehnen M., Claessen S.M., Stenner M., Huebbers C.U., et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15 (2009) 1779-1786
39. Slebos R.J., Yi Y., Ely K., Carter J., Evjen A., Zhang X., et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 701-709
40. Schlecht N.F., Burk R.D., Adrien L., Dunne A., Kawachi N., Sarta C., et al. Gene expression profiles in HPV-infected head and neck cancer. J Pathol 213 (2007) 283-293
41. Melle C., Ernst G., Winkler R., Schimmel B., Klussmann J.P., Wittekindt C., et al. Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue. Proteomics 9 (2009) 2193-2201
42. Marsit C.J., McClean M.D., Furniss C.S., and Kelsey K.T. Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. Int J Cancer 119 (2006) 1761-1766
43. Henken F.E., Wilting S.M., Overmeer R.M., van Rietschoten J.G., Nygren A.O., Errami A., et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 97 (2007) 1457-1464
44. College of American Pathologists. Cancer protocols. Head and neck cancers, 2010. .